CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Market Share Analysis
3.6. Brand Share Analysis
3.7. Value Chain Analysis
3.8. Regulatory Guidelines
3.9. Key Regulation Analysis
CHAPTER 4: NUTRIGENOMICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents and Kits
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: NUTRIGENOMICS MARKET, BY APPLICATIONS
5.1. Overview
5.1.1. Market size and forecast
5.2. Obesity
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Diabetes
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Cardiovascular Diseases
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Cancer Research
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: NUTRIGENOMICS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Online Platforms
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Hospitals and Clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NUTRIGENOMICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Applications
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product Type
7.2.5.1.2. Market size and forecast, by Applications
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product Type
7.2.5.2.2. Market size and forecast, by Applications
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product Type
7.2.5.3.2. Market size and forecast, by Applications
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Applications
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product Type
7.3.5.1.2. Market size and forecast, by Applications
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. UK
7.3.5.2.1. Market size and forecast, by Product Type
7.3.5.2.2. Market size and forecast, by Applications
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. France
7.3.5.3.1. Market size and forecast, by Product Type
7.3.5.3.2. Market size and forecast, by Applications
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Spain
7.3.5.4.1. Market size and forecast, by Product Type
7.3.5.4.2. Market size and forecast, by Applications
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Italy
7.3.5.5.1. Market size and forecast, by Product Type
7.3.5.5.2. Market size and forecast, by Applications
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product Type
7.3.5.6.2. Market size and forecast, by Applications
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Applications
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Market size and forecast, by Product Type
7.4.5.1.2. Market size and forecast, by Applications
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. Japan
7.4.5.2.1. Market size and forecast, by Product Type
7.4.5.2.2. Market size and forecast, by Applications
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product Type
7.4.5.3.2. Market size and forecast, by Applications
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. South Korea
7.4.5.4.1. Market size and forecast, by Product Type
7.4.5.4.2. Market size and forecast, by Applications
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. Australia
7.4.5.5.1. Market size and forecast, by Product Type
7.4.5.5.2. Market size and forecast, by Applications
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product Type
7.4.5.6.2. Market size and forecast, by Applications
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Applications
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product Type
7.5.5.1.2. Market size and forecast, by Applications
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. UAE
7.5.5.2.1. Market size and forecast, by Product Type
7.5.5.2.2. Market size and forecast, by Applications
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. Saudi Arabia
7.5.5.3.1. Market size and forecast, by Product Type
7.5.5.3.2. Market size and forecast, by Applications
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. South Africa
7.5.5.4.1. Market size and forecast, by Product Type
7.5.5.4.2. Market size and forecast, by Applications
7.5.5.4.3. Market size and forecast, by End User
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Market size and forecast, by Product Type
7.5.5.5.2. Market size and forecast, by Applications
7.5.5.5.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Cura Integrative Medicine
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.2. Holistic Health
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.3. Metagenics, Inc.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.4. GX Sciences Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.5. The Gene Box
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.6. Nutrigenomix Inc.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.7. Xcode Life
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.8. DNA Life
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.9. Interleukin Genetics
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.10. Genova Diagnostics
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
| ※参考情報 ニュートリゲノミクスは、栄養素と遺伝子との相互作用を研究する分野であり、個人の遺伝的情報に基づいて最適な食事や栄養補助食品を提案することを目指しています。この分野は、遺伝子が食事にどのように反応し、さまざまな健康状態や疾病リスクにどのように影響を及ぼすかを明らかにすることを目的としています。ニュートリゲノミクスは、個々の遺伝子の発現や代謝経路に栄養素が与える影響を深く掘り下げることで、パーソナライズされた栄養戦略の開発につながると期待されています。 ニュートリゲノミクスにはいくつかの種類があります。まず、遺伝子栄養学は、その中の一つで、特定の遺伝子がどのように特定の栄養素に反応するかに焦点を当てています。また、遺伝子発現解析に基づく栄養療法は、栄養素が遺伝子の発現に与える影響を調査し、それによって疾患を予防または治療する方法を模索しています。さらに、エピジェネティクスとの関連も重要です。エピジェネティクスは、環境要因が遺伝子の発現を調整するメカニズムを研究する分野であり、栄養素が遺伝子のエピジェネティックな修飾に及ぼす影響に注目しています。 ニュートリゲノミクスの用途は多岐にわたります。まず、個別化栄養プランの作成に利用されています。遺伝的背景に基づいた食事指導により、より効果的な健康管理が可能になります。たとえば、肥満や糖尿病、心血管疾患などのリスクを低減するために、特定の栄養素や食材の摂取を推奨することができます。また、特定の遺伝子型を持つ人々には、特定の栄養素がパフォーマンスや健康維持に影響を与えることから、アスリート向けの栄養指導にも役立っています。さらに、ニュートリゲノミクスは、食事と疾患の関連に関する研究においても重要な役割を果たしており、疾患予防や治療に向けた研究開発に寄与しています。 関連技術としては、次世代シーケンシング（NGS）や、ウェアラブルデバイスによるデータ収集が挙げられます。NGSは、個人の遺伝子を迅速かつ低コストで解析する技術であり、これにより、大量の遺伝情報を扱うことが可能になります。また、ウェアラブルデバイスは、個々の生活習慣や食事情報をリアルタイムで収集し、そのデータを解析することで、個別の栄養推奨をより精密に行うことができます。さらに、ビッグデータ分析技術も重要で、膨大なデータを解析することで、栄養と遺伝子の関連を探る研究が進められています。 今後の展望としては、より多くの遺伝子と栄養素との関連が特定されることで、ニュートリゲノミクスの精度が向上し、個別化栄養プランの普及が進むと考えられています。また、公共の健康戦略として、ストレス管理や慢性疾患予防の一環としてのニュートリゲノミクスの役割も期待されています。このように、ニュートリゲノミクスは、未来の健康管理や病気予防において非常に重要な領域になるでしょう。これにより、ライフスタイルに合わせた柔軟な整備が可能になり、健康的な生活をサポートすることができます。 ニュートリゲノミクスは、遺伝子と栄養素の関係を深く理解し、個人に最適な栄養アプローチを提供することで、より健康的な社会の実現に貢献していくことを目指している分野です。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
